EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

The Regulation and Function of Hippo/ YAP Pathway in Cancer

Chinmoy Ghosh, Ruchi Kakar, Seline Torkamboor, Yue Sun iD

The FASEB Journal · 15.04.2026 · 40 (7)

DOI: 10.1096/fj.202504622r ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 02.04.2026. Verfasst von Chinmoy Ghosh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth Univers…. Hauptthemen laut MEDLINE: Neoplasms, Protein Serine-Threonine Kinases, Signal Transduction, Transcription Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: HHS | NIH | National Institute of Dental and Craniofacial Research (NIDR), National Institute of Dental and Craniofacial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Hippo/YAP signaling pathway is a key regulatory network that governs organ size, tissue homeostasis, cell proliferation, and cell polarity. Aberrant Hippo/YAP signaling contributes to the initiation and progression of multiple cancers, making this pathway an attractive therapeutic target. Although several agents targeting Hippo/YAP have shown promise in preclinical models, clinical translation has been limited. These challenges likely stem from an incomplete understanding of the upstream regulators, downstream effectors, pathway crosstalk, and context‐dependent roles of Hippo/YAP across different tumor types. Continued mechanistic investigation is required to clarify these complexities and reveal new therapeutic vulnerabilities. In this review, we summarize the current knowledge of the core components of the Hippo/YAP pathway, its regulatory mechanisms and interactions with other signaling cascades, its dysregulation in cancer, the involvement of microRNAs and lncRNAs in pathway modulation, and emerging therapeutic strategies targeting Hippo/YAP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsProtein Serine-Threonine KinasesSignal TransductionTranscription FactorsAdaptor Proteins, Signal TransducingHumansAnimalsHippo Signaling PathwayYAP-Signaling ProteinsMicroRNAsGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

TEADsYAP/TAZYkicancerferroptosishippo pathwaylncRNAmicroRNA

Substanzen

Protein Serine-Threonine KinasesTranscription FactorsAdaptor Proteins, Signal TransducingYAP-Signaling ProteinsMicroRNAsYAP1 protein, human

Autor:innen und Institutionen

  • Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA.

ORCID-Profile: Yue Sun

Förderung

  • HHS | NIH | National Institute of Dental and Craniofacial Research (NIDR)
  • National Institute of Dental and Craniofacial Research

Zitieren

APA

Ghosh, C., Kakar, R., Torkamboor, S., & Sun, Y. (2026). The Regulation and Function of Hippo/ YAP Pathway in Cancer. The FASEB Journal, 40(7). https://doi.org/10.1096/fj.202504622r

Vancouver

Ghosh C, Kakar R, Torkamboor S, Sun Y. The Regulation and Function of Hippo/ YAP Pathway in Cancer. The FASEB Journal. 2026;40(7). doi:10.1096/fj.202504622r

BibTeX
@article{Ghosh2026,
  author = {Ghosh, Chinmoy and Kakar, Ruchi and Torkamboor, Seline and Sun, Yue},
  title = {The Regulation and Function of Hippo/ YAP Pathway in Cancer},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {7},
  doi = {10.1096/fj.202504622r}
}
Kostenlos starten →